2 Breakout Biotech Stocks: Ardelyx (ARDX), BioCryst Pharmaceuticals (BCRX)

Here are the top two biotech stocks to watch in the coming weeks after the recent bullish price action:-

Ardelyx Inc (NASDAQ: ARDX) was another notable stock gainer on Thursday as the stock soared as much as 10.50% after hitting a new multi-year high of $9.23. The rally in the stock was driven by news that the company’s s Japanese partner, Kyowa Kirin, has begun four late-stage clinical studies evaluating Ardelyx’s lead candidate tenapanor. We have seen a lot of buying activities in the stock since late March as the stock has soared 40% from March 29th.

ARDX stock is trading well above its 50-Day and the 200-Day moving average price of $6.97 and $6.33 respectively. Considering the stock keeps on hitting new highs, ARDX stock may be a better momentum play on intermediate pullbacks

Related:  Senseonics (SENS) Extends The Fall Ahead of Earnings

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) was among the most active biotech stock gainer after important news related to its hereditary angioedema (HAE) treatment, Orladeyo. Shares of the biotech company soared 11.30% and closed at $11.34. BCRX stock has already gained 53% so far this year.

One must note that the company closed above its 50-Day moving average price of $10.97. Moreover, the stock is trading well above its 200-Day moving average price of $6.70. So considering yesterday’s breakout, BCRX stock may continue to do well.

Uson Abdilazhanov

Editor and Computer Expert A hardcore tech enthusiast and computer expert Uson Abdilazhanov who holds a degree in communications started writing in his personal blogs since 2012. That time he was interested in the technical part of the computer. But now the software aspect plays an important role in his career. Currently, he runs a PC building and repairing shop which helps a lot of designers and gamers who always like to try new things.